{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T13:37:19Z","timestamp":1709473039971},"posted":{"date-parts":[[2023,8,11]]},"group-title":"In Review","reference-count":37,"publisher":"Research Square Platform LLC","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,8,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n        <jats:p><jats:bold>Background<\/jats:bold>\nMedications for opioid use disorder (MOUD) such as buprenorphine is effective for treating opioid use disorder (OUD). START NOW (SN) is a manualized, skills-based group psychotherapy originally developed and validated for the correctional population and has been shown to result in reduced risk of disciplinary infractions and future psychiatric inpatient days with a dose response effect. We investigate whether adapted START NOW is effective for treating OUD in a MOUD office-based opioid treatment (OBOT) setting in this non-inferiority clinical trial.\n<jats:bold>Methods<\/jats:bold>\nPatients enrolled in once weekly buprenorphine\/suboxone MOUD OBOT were eligible for enrollment in this study. Participants were cluster-randomized, individually-randomized, or not randomized into either START NOW psychotherapy or treatment-as-usual (TAU) for 32 weeks of therapy. Treatment effectiveness was measured as the number of groups attended, treatment duration, intensity of attendance, and overall drug use as determined by drug screens.\n<jats:bold>Results<\/jats:bold>\n137 participants were quasi-randomized to participate in SN (n\u2009=\u200979) or TAU (n\u2009=\u200958). Participants receiving START NOW psychotherapy, when compared to TAU, had comparable number of groups attended (16.5 vs. 16.7, p\u2009=\u20090.80), treatment duration in weeks (24.1 vs. 23.8, p\u2009=\u20090.62), and intensity defined by number of groups attended divided by the number of weeks to last group (0.71 vs. 0.71, p\u2009=\u20090.90). SN compared to TAU also had similar rates of any positive drug screen result (81.0% vs. 91.4%, p\u2009=\u20090.16). This suggests that adapted START NOW is noninferior to TAU, or the standard of care at our institution, for treating opioid use disorder.\n<jats:bold>Conclusion<\/jats:bold>\nAdapted START NOW is an effective psychotherapy for treating OUD when paired with buprenorphine\/naloxone in the outpatient group therapy setting. Always free and publicly available, START NOW psychotherapy, along with its clinician manual and training materials, are easily accessible and distributable and may be especially useful for low-resource settings in need of evidence-based psychotherapy.<\/jats:p>","DOI":"10.21203\/rs.3.rs-3229052\/v1","type":"posted-content","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T14:00:16Z","timestamp":1691762416000},"source":"Crossref","is-referenced-by-count":0,"title":["Noninferiority Clinical Trial of Adapted START NOW Psychotherapy for Outpatient Opioid Treatment"],"prefix":"10.21203","author":[{"given":"Albert","family":"Truong","sequence":"first","affiliation":[{"name":"Virginia Tech"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Kablinger","sequence":"additional","affiliation":[{"name":"Carilion Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheri","family":"Hartman","sequence":"additional","affiliation":[{"name":"Carilion Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hartman","sequence":"additional","affiliation":[{"name":"Carilion Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"West","sequence":"additional","affiliation":[{"name":"Virginia Tech"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Hanlon","sequence":"additional","affiliation":[{"name":"Virginia Tech"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Lozano","sequence":"additional","affiliation":[{"name":"Virginia Tech"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"McNamara","sequence":"additional","affiliation":[{"name":"Carilion Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Seidel","sequence":"additional","affiliation":[{"name":"Carilion Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Trestman","sequence":"additional","affiliation":[{"name":"Carilion Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8761","reference":[{"key":"ref1","author":"McCance-Katz EF","year":"2019","unstructured":"McCance-Katz EF, The National Survey on Drug Use and Health. : 2019: SAMHSA; 2020 [Available from: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt29392\/Assistant-Secretary-nsduh2019_presentation\/Assistant-Secretary-nsduh2019_presentation.pdf."},{"key":"ref2","unstructured":"Administration SAaMHS. Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health 2020 [Available from: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt35325\/NSDUHFFRPDFWHTMLFiles2020\/2020NSDUHFFR1PDFW102121.pdf."},{"key":"ref3","volume-title":"Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction","author":"Center for Substance Abuse T. SAMHSA\/CSAT Treatment Improvement Protocols","year":"2004","unstructured":"Center for Substance Abuse T. SAMHSA\/CSAT Treatment Improvement Protocols. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2004."},{"key":"ref4","author":"Rinaldo SG","unstructured":"Rinaldo SG, Rinaldo DW. Availability Without Accessibility? State Medicaid Coverage and Authorization Requirements for Opioid Dependence Medications: American Society of Addiction Medicine; 2013 [Available from: https:\/\/nosorh.org\/wp-content\/uploads\/2017\/05\/Access-to-MAT-by-state.pdf."},{"key":"ref5","volume-title":"Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence","author":"WHO","year":"2009","unstructured":"WHO. Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. Geneva, Switzerland: World Health Organization; 2009."},{"issue":"8","key":"ref6","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.2105\/AJPH.2015.302664","article-title":"National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment","volume":"105","author":"Jones CM","year":"2015","unstructured":"Jones CM, Campopiano M, Baldwin G, McCance-Katz E. National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment. Am J Public Health. 2015;105(8):e55\u201363.","journal-title":"Am J Public Health"},{"key":"ref7","author":"Ghertner R","unstructured":"Ghertner R, Groves L. The Opioid Crisis and Economic Opportunity: Geographic and Economic Trends: U.S. Department of Health and Human Services; 2018 [updated September 11, 2018. Available from: https:\/\/aspe.hhs.gov\/sites\/default\/files\/private\/pdf\/259261\/ASPEEconomicOpportunityOpioidCrisis.pdf."},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2105\/AJPH.94.1.103","article-title":"Are rates of psychiatric disorders in the homeless population changing?","volume":"94","author":"North CS","year":"2004","unstructured":"North CS, Eyrich KM, Pollio DE, Spitznagel EL. Are rates of psychiatric disorders in the homeless population changing? Am J Public Health. 2004;94(1):103\u20138.","journal-title":"Am J Public Health"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1521-0391.2012.12008.x","article-title":"Frequency and severity of comorbid mood and anxiety disorders in prescription opioid dependence","volume":"22","author":"Gros DF","year":"2013","unstructured":"Gros DF, Milanak ME, Brady KT, Back SE. Frequency and severity of comorbid mood and anxiety disorders in prescription opioid dependence. Am J Addict. 2013;22(3):261\u20135.","journal-title":"Am J Addict"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1017\/S0033291711002145","article-title":"Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions","volume":"42","author":"Martins SS","year":"2012","unstructured":"Martins SS, Fenton MC, Keyes KM, Blanco C, Zhu H, Storr CL. Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychol Med. 2012;42(6):1261\u201372.","journal-title":"Psychol Med"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/ADM.0000000000000193","article-title":"A Systematic Review on the Use of Psychosocial Interventions in Conjunction With Medications for the Treatment of Opioid Addiction","volume":"10","author":"Dugosh K","year":"2016","unstructured":"Dugosh K, Abraham A, Seymour B, McLoyd K, Chalk M, Festinger D. A Systematic Review on the Use of Psychosocial Interventions in Conjunction With Medications for the Treatment of Opioid Addiction. J Addict Med. 2016;10(2):93\u2013103.","journal-title":"J Addict Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2147\/IJGM.S295461","article-title":"Therapeutic Approaches to Opioid Use Disorder: What is the Current Standard of Care?","volume":"14","author":"Carley JA","year":"2021","unstructured":"Carley JA, Oesterle T. Therapeutic Approaches to Opioid Use Disorder: What is the Current Standard of Care? Int J Gen Med. 2021;14:2305\u201311.","journal-title":"Int J Gen Med"},{"key":"ref13","author":"Sampl S","year":"2018","unstructured":"Sampl S, Trestman RL, Krauss WJ, Guiher J. START NOW Facilitator Manual, Version 3.0: Carilion Clinic; 2018 [updated May 24, 2018. Available from: https:\/\/www.carilionclinic.org\/sites\/default\/files\/2019-07\/START_NOW_facilitator_manual_v3.0_05242018.pdf."},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12888-020-03024-x","article-title":"Systematic content analysis of patient evaluations of START NOW psychotherapy reveals practical strategies for improving the treatment of opioid use disorder","volume":"21","author":"Truong AY","year":"2021","unstructured":"Truong AY, Saway BF, Bouzaher MH, Rasheed MN, Monjazeb S, Everest SD, et al. Systematic content analysis of patient evaluations of START NOW psychotherapy reveals practical strategies for improving the treatment of opioid use disorder. BMC Psychiatry. 2021;21(1):23.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1176\/appi.ps.201400471","article-title":"Evaluating START NOW: A Skills-Based Psychotherapy for Inmates of Correctional Systems","volume":"67","author":"Kersten L","year":"2016","unstructured":"Kersten L, Cislo AM, Lynch M, Shea K, Trestman RL. Evaluating START NOW: A Skills-Based Psychotherapy for Inmates of Correctional Systems. Psychiatr Serv. 2016;67(1):37\u201342.","journal-title":"Psychiatr Serv"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1176\/appi.ps.201500456","article-title":"Psychiatric Hospitalization After Participation in START NOW","volume":"67","author":"Cislo AM","year":"2016","unstructured":"Cislo AM, Trestman RL. Psychiatric Hospitalization After Participation in START NOW. Psychiatr Serv. 2016;67(1):143.","journal-title":"Psychiatr Serv"},{"issue":"5\u20136","key":"ref17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/bsl.2302","article-title":"Evaluation of CT's ASIST program: Specialized services to divert higher risk defendants","volume":"35","author":"Frisman LK","year":"2017","unstructured":"Frisman LK, Lin HJ, Rodis ET, Grzelak J, Aiello M. Evaluation of CT's ASIST program: Specialized services to divert higher risk defendants. Behav Sci Law. 2017;35(5\u20136):550\u201361.","journal-title":"Behav Sci Law"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/s13063-016-1705-6","article-title":"START NOW - a comprehensive skills training programme for female adolescents with oppositional defiant and conduct disorders: study protocol for a cluster-randomised controlled trial","volume":"17","author":"Kersten L","year":"2016","unstructured":"Kersten L, Pr\u00e4tzlich M, Mannstadt S, Ackermann K, Kohls G, Oldenhof H, et al. START NOW - a comprehensive skills training programme for female adolescents with oppositional defiant and conduct disorders: study protocol for a cluster-randomised controlled trial. Trials. 2016;17(1):568.","journal-title":"Trials"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.euroneuro.2019.09.045","article-title":"S.19.04 Start now: A program to improve emotion regulation in female patients with disruptive behaviour disorder","volume":"29","author":"Stadler C","year":"2019","unstructured":"Stadler C, Konrad K, Popma A, Kirchner M, Freitag C. S.19.04 Start now: A program to improve emotion regulation in female patients with disruptive behaviour disorder. Eur Neuropsychopharmacol. 2019;29:14.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris PA","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.11613\/BM.2016.015","article-title":"Understanding the effect size and its measures","volume":"26","author":"Ialongo C","year":"2016","unstructured":"Ialongo C. Understanding the effect size and its measures. Biochem Med (Zagreb). 2016;26(2):150\u201363.","journal-title":"Biochem Med (Zagreb)"},{"issue":"7447","key":"ref22","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/bmj.328.7447.1073","article-title":"The logrank test","volume":"328","author":"Bland JM","year":"2004","unstructured":"Bland JM, Altman DG. The logrank test. BMJ. 2004;328(7447):1073.","journal-title":"BMJ"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.drugalcdep.2018.12.030","article-title":"Co-occurring substance use and mental disorders among adults with opioid use disorder","volume":"197","author":"Jones CM","year":"2019","unstructured":"Jones CM, McCance-Katz EF. Co-occurring substance use and mental disorders among adults with opioid use disorder. Drug Alcohol Depend. 2019;197:78\u201382.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12402-016-0195-4","article-title":"Skills training groups for men with ADHD in compulsory care due to substance use disorder: a feasibility study","volume":"8","author":"Bihlar Muld B","year":"2016","unstructured":"Bihlar Muld B, Jokinen J, B\u00f6lte S, Hirvikoski T. Skills training groups for men with ADHD in compulsory care due to substance use disorder: a feasibility study. Atten Defic Hyperact Disord. 2016;8(3):159\u201372.","journal-title":"Atten Defic Hyperact Disord"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/15504263.2018.1548719","article-title":"Field Test of a Dialectical Behavior Therapy Skills Training-Based Intervention for Smoking Cessation and Opioid Relapse Prevention in Methadone Treatment","volume":"15","author":"Cooperman NA","year":"2019","unstructured":"Cooperman NA, Rizvi SL, Hughes CD, Williams JM. Field Test of a Dialectical Behavior Therapy Skills Training-Based Intervention for Smoking Cessation and Opioid Relapse Prevention in Methadone Treatment. J Dual Diagn. 2019;15(1):67\u201373.","journal-title":"J Dual Diagn"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use","volume":"9","author":"Kampman K","year":"2015","unstructured":"Kampman K, Jarvis M. American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. J Addict Med. 2015;9(5):358\u201367.","journal-title":"J Addict Med"},{"issue":"9","key":"ref27","doi-asserted-by":"crossref","first-page":"E247","DOI":"10.1503\/cmaj.170958","article-title":"Management of opioid use disorders: a national clinical practice guideline","volume":"190","author":"Bruneau J","year":"2018","unstructured":"Bruneau J, Ahamad K, Goyer M, Poulin G, Selby P, Fischer B, et al. Management of opioid use disorders: a national clinical practice guideline. CMAJ. 2018;190(9):E247\u2013e57.","journal-title":"CMAJ"},{"issue":"10","key":"ref28","doi-asserted-by":"crossref","first-page":"e0186315","DOI":"10.1371\/journal.pone.0186315","article-title":"Primary care models for treating opioid use disorders: What actually works? A systematic review","volume":"12","author":"Lagisetty P","year":"2017","unstructured":"Lagisetty P, Klasa K, Bush C, Heisler M, Chopra V, Bohnert A. Primary care models for treating opioid use disorders: What actually works? A systematic review. PLoS ONE. 2017;12(10):e0186315.","journal-title":"PLoS ONE"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/ADM.0000000000000523","article-title":"Disparities Between US Opioid Overdose Deaths and Treatment Capacity: A Geospatial and Descriptive Analysis","volume":"13","author":"Langabeer JR","year":"2019","unstructured":"Langabeer JR, Gourishankar A, Chambers KA, Giri S, Madu R, Champagne-Langabeer T. Disparities Between US Opioid Overdose Deaths and Treatment Capacity: A Geospatial and Descriptive Analysis. J Addict Med. 2019;13(6):476\u201382.","journal-title":"J Addict Med"},{"issue":"7","key":"ref30","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0706743717711167","article-title":"The State of Opioid Agonist Therapy in Canada 20 Years after Federal Oversight","volume":"62","author":"Eibl JK","year":"2017","unstructured":"Eibl JK, Morin K, Leinonen E, Marsh DC. The State of Opioid Agonist Therapy in Canada 20 Years after Federal Oversight. Can J Psychiatry. 2017;62(7):444\u201350.","journal-title":"Can J Psychiatry"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jval.2020.08.2098","article-title":"Disparities in Access to Opioid Treatment Programs and Office-Based Buprenorphine Treatment Across the Rural-Urban and Area Deprivation Continua: A US Nationwide Small Area Analysis","volume":"24","author":"Amiri S","year":"2021","unstructured":"Amiri S, McDonell MG, Denney JT, Buchwald D, Amram O. Disparities in Access to Opioid Treatment Programs and Office-Based Buprenorphine Treatment Across the Rural-Urban and Area Deprivation Continua: A US Nationwide Small Area Analysis. Value Health. 2021;24(2):188\u201395.","journal-title":"Value Health"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"112452","DOI":"10.1016\/j.psychres.2019.06.027","article-title":"Experimental and quasi-experimental designs in implementation research","volume":"283","author":"Miller CJ","year":"2020","unstructured":"Miller CJ, Smith SN, Pugatch M. Experimental and quasi-experimental designs in implementation research. Psychiatry Res. 2020;283:112452.","journal-title":"Psychiatry Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1146\/annurev-publhealth-040617-014128","article-title":"Selecting and Improving Quasi-Experimental Designs in Effectiveness and Implementation Research","volume":"39","author":"Handley MA","year":"2018","unstructured":"Handley MA, Lyles CR, McCulloch C, Cattamanchi A. Selecting and Improving Quasi-Experimental Designs in Effectiveness and Implementation Research. Annu Rev Public Health. 2018;39:5\u201325.","journal-title":"Annu Rev Public Health"},{"issue":"2\u20133","key":"ref34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ctim.2004.07.043","article-title":"Pragmatic clinical trials","volume":"12","author":"Macpherson H","year":"2004","unstructured":"Macpherson H. Pragmatic clinical trials. Complement Ther Med. 2004;12(2\u20133):136\u201340.","journal-title":"Complement Ther Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jsat.2017.11.003","article-title":"Group-based treatment of opioid use disorder with buprenorphine: A systematic review","volume":"84","author":"Sokol R","year":"2018","unstructured":"Sokol R, LaVertu AE, Morrill D, Albanese C, Schuman-Olivier Z. Group-based treatment of opioid use disorder with buprenorphine: A systematic review. J Subst Abuse Treat. 2018;84:78\u201387.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.fertnstert.2017.06.011","article-title":"Treatments for opioid use disorder among pregnant and reproductive-aged women","volume":"108","author":"Hand DJ","year":"2017","unstructured":"Hand DJ, Short VL, Abatemarco DJ. Treatments for opioid use disorder among pregnant and reproductive-aged women. Fertil Steril. 2017;108(2):222\u20137.","journal-title":"Fertil Steril"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2149","article-title":"Primary Care-Based Models for the Treatment of Opioid Use Disorder: A Scoping Review","volume":"166","author":"Korthuis PT","year":"2017","unstructured":"Korthuis PT, McCarty D, Weimer M, Bougatsos C, Blazina I, Zakher B, et al. Primary Care-Based Models for the Treatment of Opioid Use Disorder: A Scoping Review. Ann Intern Med. 2017;166(4):268\u201378.","journal-title":"Ann Intern Med"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3229052\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3229052\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T01:23:37Z","timestamp":1706837017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3229052\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":37,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3229052\/v1","relation":{},"subject":[],"published":{"date-parts":[[2023,8,11]]},"subtype":"preprint"}}